Yungblud (Dominic Richard Harrison) has canceled all remaining shows for 2025 after routine tests raised medical concerns that his doctors say require an immediate stop to touring. The decision — announced by the artist on Nov. 15 on Instagram and reported by Loudwire the following day — affects scheduled U.S. shows as well as dates in Mexico City and across Latin America.
In his Instagram message, Yungblud opened with gratitude: “This year has been truly unbelievable and I feel so lucky and honoured from everything that has happened.” He revealed that recent routine testing after getting home from the road showed troubling results, writing plainly that “my voice and blood tests have raised some concerns.” He added that doctors have ordered him to rest and to stop touring “until the end of the year.”
He acknowledged how hard the choice was, saying “My heart is broken” and admitting his tendency to push himself: “It is in my nature to run and run until I run myself to the ground … but this time I’ve been told I have to take it seriously and I can’t fuck around.” He promised fans he doesn’t want any permanent damage and vowed to make it up to them.
Yungblud referenced the impacted regions in his announcement; the affected U.S. and regional shows include the following confirmed dates from his official tour listing and ticket sites — all of which have been canceled or paused while refunds are processed:
• Nov. 19, 2025 — The Met, Philadelphia, PA.
• Nov. 23, 2025 — Agora Theatre & Ballroom, Cleveland, OH.
• Nov. 25–26, 2025 — 9:30 Club, Washington, D.C. (two Washington dates listed on tour pages).
• Mexico City and multiple Latin America dates — cited by Yungblud in the post; the artist said Mexico/LatAm plans are being reworked for more affordable shows next year.
Major outlets reporting the cancellations note the same cities and dates above. Billboard lists Philadelphia (Nov. 19), Cleveland (Nov. 23) and Washington, D.C. (Nov. 25–26) among the canceled stops.
Yungblud told fans “All US tickets will be refunded.” He also asked fans to sign up at a link he provided so he can send them “a gift” as a thank-you for their support, and promised “USA I will see you next year.” He said Mexico and Latin America will be reconsidered for more affordable solo shows in 2026.
He framed the cancellation as short-term but serious: he didn’t give medical specifics beyond the alarming voice and bloodwork, but stressed he will not risk long-term damage and wants to preserve his ability to perform in the future.
Yungblud has spent much of 2025 supporting his fourth LP, Idols (released June 2025), and has been highly visible this year — from tribute performances at major events to collaborations and awards attention. Loudwire notes he was recently nominated for multiple 2026 Grammy categories, collaborated with Aerosmith on new material, and performed at high-profile events this year — all of which make this pause especially significant for a career on the rise.
Loudwire also reminds readers that Yungblud previously withdrew from the 2025 Loserville tour; that absence is now clearer in context given this latest medical update.
Responses across social platforms were overwhelmingly supportive. Loudwire captured Facebook replies urging balance and recovery, with fans telling him to prioritize his health and promising they’ll be there when he’s ready to return.
Yungblud’s official tour page still shows a heavy 2026 slate — Australia, the U.K. and an expanded North American run — indicating the artist and his team are already planning the next chapter once he recovers. Loudwire notes the artist’s One More Time EP with Aerosmith is due Nov. 21, 2025, and that Yungblud is set for a large 2026 schedule.
